Acute Myeloid Leukemia in Adults

We offer compassionate care throughout the diagnosis and treatment of acute myeloid leukemia, a rapidly growing cancer of blood-forming cells in the bone marrow, the spongy tissue in the center of bones. Our hematologist–oncologists use the latest diagnostic tools, such as molecular profiling and chromosome analysis, to create a personalized treatment plan for you. Our goal is to manage this cancer quickly with the goal of achieving remission, in which cancer cells are no longer detected in the blood.

Clinical Trials and Research Studies

Phase 6

A Multi-center Open-label Single-arm Phase 2/3 Trial Evaluating the Safety and Pharmacokinetics of Calaspargase Pegol for Treatment of Adults Aged 22 To >65 Years with Newly-diagnosed Philadelphia-negative ALL

Learn More

Phase 2

A Phase IIa Open-label Clinical Trial to Evaluate the Safety Pharmacokinetics Pharmacodynamics and Efficacy of BP1001 (a Liposomal Grb2 Antisense Oligonucleotide) in Combination with Venetoclax plus Decitabine in Patients with Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Induction Therapy

Learn More

Phase 3

AALL1631: International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Ph+ ALL Testing Imatinib in Combination with Two Different Cytotoxic Chemotherapy Backbones

Learn More

Phase 1

A Phase 1 Open-label Multicenter Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of IGM-2323 in Subjects with Relapsed/Refractory Non-Hodgkin Lymphomas

Learn More